Standard operating procedures of the electrochemotherapy: Instructions for the use of bleomycin or cisplatin administered either systemically or locally and electric pulses delivered by the CliniporatorTM by means of invasive or non-invasive electrod
about
Tumor ablation with irreversible electroporationElectrochemotherapy: technological advancements for efficient electroporation-based treatment of internal tumorsElectroporation-based treatment planning for deep-seated tumors based on automatic liver segmentation of MRI imagesElectrochemotherapy: a new technological approach in treatment of metastases in the liverTherapy for unresectable recurrent and in-transit extremity melanoma.Electrochemotherapy efficacy evaluation for treatment of locally advanced stage III cutaneous squamous cell carcinoma: a 22-cases retrospective analysis.Basal cell carcinoma: 10-year experience with electrochemotherapy.Antivascular effects of electrochemotherapy: implications in treatment of bleeding metastases.Electrochemotherapy for treatment of skin and soft tissue tumours. Update and definition of its role in multimodal therapy.Educational application for visualization and analysis of electric field strength in multiple electrode electroporationUse of electrochemotherapy in a case of neck skin metastasis of oral squamous cell carcinoma: case report and considerations.The role of pH fronts in tissue electroporation based treatments.Management of cutaneous metastases using electrochemotherapyModeling of microvascular permeability changes after electroporationThe role of additional pulses in electropermeabilization protocols.Assessing a novel immuno-oncology-based combination therapy: Ipilimumab plus electrochemotherapy.Calcium Electroporation: Evidence for Differential Effects in Normal and Malignant Cell Lines, Evaluated in a 3D Spheroid Model.Cell Electrosensitization Exists Only in Certain Electroporation BuffersElectrochemotherapy in the Treatment of Cutaneous Metastases from Breast Cancer: A Multicenter Cohort Analysis.The promising alliance of anti-cancer electrochemotherapy with immunotherapyElectrochemotherapy: an emerging cancer treatment.Ipilimumab (Anti-Ctla-4 Mab) in the treatment of metastatic melanoma: Effectiveness and toxicity management.Asymmetric Waveforms Decrease Lethal Thresholds in High Frequency Irreversible Electroporation Therapies.Electrodes for in vivo localised subcutaneous electropulsation and associated drug and nucleic acid delivery.Microsecond and nanosecond electric pulses in cancer treatments.Preclinical models in electrochemotherapy: the role of veterinary patients.Treatment of metastatic melanoma with electrochemotherapy.Locally enhanced chemotherapy by electroporation: clinical experiences and perspective of use of electrochemotherapy.Mechanisms of transfer of bioactive molecules through the cell membrane by electroporation.The controversial role of electrochemotherapy in head and neck cancer: a systematic review of the literature.Electrochemotherapy of mucosal head and neck tumors: a systematic review.Modulation of activity of known cytotoxic ruthenium(III) compound (KP418) with hampered transmembrane transport in electrochemotherapy in vitro and in vivo.Long-term follow-up in patients treated with curative electrochemotherapy for cancer in the oral cavity and oropharynx.Electrochemotherapy in the treatment of metastatic malignant melanoma: a prospective cohort study by InspECT.Optimization of electric pulse amplitude and frequency in vitro for low voltage and high frequency electrochemotherapy.Low electric field parameters required to induce death of cancer cells.Effective treatment of intractable cutaneous metastases of breast cancer with electrochemotherapy: Ten-year audit of single centre experience.Local treatment with electrochemotherapy of superficial angiosarcomas: Efficacy and safety results from a multi-institutional retrospective study.Bleomycin delivery into cancer cells in vitro with ultrasound and SonoVue® or BR14® microbubbles.Magnetic fields with frequency of 217 Hz can reduce cell apoptosis caused by electrochemotherapy.
P2860
Q21144414-9C368321-9B93-42EF-B582-90F47097C9C8Q26822537-852533A4-9C54-4D09-90DA-284088F5E3D5Q28535068-51273EC4-0757-4E8B-A167-7AE99036A9A6Q30557077-1C55ED29-77E5-4D43-8841-51A38B1C25C4Q33348506-60E4796D-877D-4BC2-9957-506EBFE74981Q33604418-9EBA9D83-1992-42FB-B022-7A3309292162Q33750383-F0CB0C60-C043-42B0-A985-45968CC4DE08Q34022431-B6C38505-B2F4-404D-83FC-29EFB2BBCC2BQ34025351-E8789342-27D6-47A0-8042-E979E9E0E96DQ34459739-BEF9978B-DE32-4DA7-A3E2-9152D63A1D3AQ34643782-4BA81971-E72C-4C54-B19D-64B30DDEAE64Q35053493-6F6F851C-ED1F-4C53-866C-BE233CBE9B6BQ35089988-00339D93-CCB8-4E0B-9977-8229925DAABFQ35203487-28D729B6-06E8-442A-8CF8-FF78A24417F5Q35463498-1BD51544-DBB9-4A5D-BE49-3AB74B5D72E0Q35798996-4C1CC93D-5E5D-485D-92D3-A4E3497FF503Q35860243-C00384CF-AEFE-422B-BE4B-87CA32C5D24DQ36084500-3FC28DEE-A1CD-4E72-9D77-02F521C5E6FEQ36391779-57321938-7130-40D0-9BDF-08006CA7EAFAQ37014373-7B7BEDFD-3A64-4FB5-8AF2-1726057A4377Q37130253-FD5D5D03-333B-482D-93CC-9163B91B8305Q37131014-DFB8996B-D83D-4D8D-8AE9-3817C98FB3F6Q37595430-28EA796B-6E47-4A08-B5B7-C7B76EA6B2EEQ37622247-B6254B38-9C58-4D0E-BD1B-3E9D299DE0B8Q37910836-8C70A0A9-8E2C-4B34-A1AB-58DB98D31177Q38029365-77A09577-93A6-45A0-8CFA-95E4617B264BQ38200101-37A4F247-825D-42BF-B066-A1549F98F382Q38209607-4BE8B793-ABF2-4256-B74C-012F88650B79Q38458324-85ABF0EF-0208-44F7-A768-81678430E9CEQ38943085-A6189D08-4922-4080-8214-83E8A7068527Q38972686-6DD26CA0-FE73-4841-A983-CB147977C545Q38981930-4A732184-CC52-4274-BC18-98ABA827CF0CQ38997121-34B34E78-A388-444B-ABB4-A71DE2136196Q39001667-47BAA063-A4AC-48CF-9F1C-B6FE81E7DA4AQ39056177-EE53F0CB-1732-4BCC-BC0C-15CBB25FF4DAQ39144552-8C970EDA-3EAE-475A-BC3E-B84314A2A545Q39160647-EFF1B9DC-6A06-430C-9FC7-2BDC29A39D12Q39172952-0D8C7A46-9F90-4188-B3DB-546DCE6B7065Q39207431-E0A610BE-74F0-4D02-82C0-1D592F44486BQ39210154-198A51F9-9552-4FF4-98E2-047C7A478DDC
P2860
Standard operating procedures of the electrochemotherapy: Instructions for the use of bleomycin or cisplatin administered either systemically or locally and electric pulses delivered by the CliniporatorTM by means of invasive or non-invasive electrod
description
wetenschappelijk artikel
@nl
наукова стаття, опублікована в листопаді 2006
@uk
name
Standard operating procedures ...... asive or non-invasive electrod
@en
Standard operating procedures ...... asive or non-invasive electrod
@nl
type
label
Standard operating procedures ...... asive or non-invasive electrod
@en
Standard operating procedures ...... asive or non-invasive electrod
@nl
prefLabel
Standard operating procedures ...... asive or non-invasive electrod
@en
Standard operating procedures ...... asive or non-invasive electrod
@nl
P2093
P1433
P1476
Standard operating procedures ...... asive or non-invasive electrod
@en
P2093
Christopher G. Collins
Gerald C. O’Sullivan
Gregor Sersa
Jean-Rémi Garbay
Julie Gehl
Lluis M. Mir
Michel Marty
Poul F. Geertsen
Valérie Billard
P356
10.1016/J.EJCSUP.2006.08.003
P577
2006-11-01T00:00:00Z